drug
brelovitug
Phase 3updated 5mo agoby $MIRM Mirum Pharmaceuticals, Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying brelovitug
- phase3Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
- phase3A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
- phase3A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection
- phase3A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)
News(2)
- PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approvalA former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.biopharma_dive · 3d ago
- Mirum posts phase 3 hepatitis win for ‘commercially differentiated’ challenger to Gilead, VirA phase 3 trial of Mirum Pharmaceuticals’ chronic hepatitis delta virus drug candidate has hit its primary endpoint, furthering the biotech’s efforts to enter a space recently colonized by Gilead S…fiercebiotech · 6d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that